News Releases

Select year
Categories

Myriad Genetics to Present at the 2013 J.P. Morgan Annual Healthcare Conference

Dec 17, 2012 | Corporate

Read more

Myriad Announces Diabetes Collaboration With Sanofi

Dec 10, 2012 | Pipeline

Read more

Myriad Genetics' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer

Dec 07, 2012 | Pipeline

Read more

Supreme Court of the United States to Hear Isolated DNA Patent Case

Nov 30, 2012 | Corporate

Read more

Myriad Genetics' Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy

Nov 28, 2012 | Products

Read more

Myriad Genetics to Present at the Piper Jaffray Healthcare Conference

Nov 15, 2012 | Corporate

Read more

Myriad Genetics Reports First Quarter Fiscal Year 2013 Results

Nov 05, 2012 | Financial

Read more

Myriad Genetics to Present at the 2012 Credit Suisse Annual Healthcare Conference

Nov 01, 2012 | Corporate

Read more

Myriad Genetics to Announce First Fiscal Quarter 2013 Results on Monday, November 5, 2012

Oct 15, 2012 | Financial

Read more

Myriad's HRD Score Detects Loss of DNA Repair Function in Ovarian Cancer

Oct 10, 2012 | Pipeline

Read more

Myriad Genetics Sponsors Cancer Awareness Initiatives in Support of National Hereditary Breast and Ovarian Cancer Week

Oct 03, 2012 | Corporate

Read more

Noridian Notifies Myriad of Initial Draft Decision to Classify Prolaris® as a Non-Covered Service

Sep 24, 2012 | Products

Read more

Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference

Aug 30, 2012 | Corporate

Read more

U.S Court of Appeals Upholds Myriad's Gene Patents

Aug 16, 2012 | Corporate

Read more

Myriad Genetics Reports Fourth Quarter and Fiscal Year 2012 Results

Aug 14, 2012 | Financial

Read more

Myriad Genetics and Pharma Mar Enter Into Companion Diagnostic Agreement

Jul 26, 2012 | Pipeline

Read more

Myriad Genetics to Announce Fiscal Fourth Quarter and Fiscal Year 2012 Results on Tuesday, August 14, 2012

Jul 24, 2012 | Financial

Read more

Myriad Genetics Receives the Charles R. Smart Visionary Award From the American Cancer Society®

Jun 06, 2012 | Corporate

Read more

Myriad's Lung Cancer Prognosis Test Shown to Significantly Predict Survival in Early Stage Lung Cancer Patients

Jun 04, 2012 | Products

Read more

Myriad Genetics to Present at Upcoming Investor Conferences in June

May 22, 2012 | Corporate

Read more

Myriad Genetics Announces Presentation of Lung Cancer Study at American Society for Clinical Oncology Annual Meeting

May 16, 2012 | Products

Read more

Myriad RBM Announces the Launch of OncologyMAP® v. 2.0

May 09, 2012 | Products

Read more

Myriad Genetics Reports Record Third Fiscal Quarter 2012 Results

May 01, 2012 | Financial

Read more

Myriad Genetics to Announce Fiscal 2012 Third Quarter Results on Tuesday, May 1, 2012

Apr 10, 2012 | Financial

Read more

Myriad Study Finds High Prevalence of Mutations in the PMS2 Gene

Mar 29, 2012 | Pipeline

Read more

Myriad and Cephalon Enter Into Companion Diagnostic Agreement

Mar 28, 2012 | Pipeline

Read more

Supreme Court of the United States Remands Gene Patenting Case

Mar 26, 2012 | Corporate

Read more

Prolaris® Test Awarded Best Poster Honor at 27th Annual EAU Congress in Paris, France

Feb 27, 2012 | Products

Read more

Myriad's Prolaris® Test Shown to Significantly Predict Prostate Cancer Outcome in Needle Biopsy Tissue

Feb 24, 2012 | Products

Read more

Myriad Genetics to Present at the Cowen and Company 32nd Annual Health Care Conference

Feb 22, 2012 | Corporate

Read more

Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference

Feb 06, 2012 | Corporate

Read more

Myriad's Prolaris® Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy

Feb 02, 2012 | Products

Read more

Myriad Genetics Reports Second Quarter Fiscal Year 2012 Results

Jan 31, 2012 | Financial

Read more

Myriad Genetics Acquires Exclusive Rights to RAD51C Gene

Jan 18, 2012 | Corporate

Read more

Myriad Genetics to Announce Fiscal 2012 Second Quarter Results on Tuesday, January 31, 2012

Jan 17, 2012 | Financial

Read more